Risk factors and a 3-month risk score for predicting pacemaker implantation in patients with atrial fibrillations

by Christian Torp-Pedersen, Frederik Dalgaard, Tommi Bo Lindhardt, Martin H Ruwald, Jannik Langtved Pallisgaard, Paul Blanche
Published 2020-06-01

Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.

by Frederik Dalgaard, Martin H Ruwald, Tommi Bo Lindhardt, Gunnar H Gislason, Christian Torp-Pedersen, Jannik L Pallisgaard
Published 2018-01-01

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.

by Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Morten Lock Hansen, Anne-Marie Schjerning, Jonas Bjerring Olesen, Laila Staerk, Christian Torp-Pedersen, Gunnar Hilmar Gislason
Published 2015-01-01

Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.

by Jannik Langtved Pallisgaard, Gunnar Hilmar Gislason, Christian Torp-Pedersen, Christina Ji-Young Lee, Caroline Sindet-Pedersen, Laila Staerk, Jonas Bjerring Olesen, Tommi Bo Lindhardt
Published 2016-01-01